136 related articles for article (PubMed ID: 10878394)
1. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes.
Posavad CM; Huang ML; Barcy S; Koelle DM; Corey L
J Immunol; 2000 Jul; 165(2):1146-52. PubMed ID: 10878394
[TBL] [Abstract][Full Text] [Related]
2. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
Koelle DM; Chen HB; Gavin MA; Wald A; Kwok WW; Corey L
J Immunol; 2001 Mar; 166(6):4049-58. PubMed ID: 11238653
[TBL] [Abstract][Full Text] [Related]
3. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
[TBL] [Abstract][Full Text] [Related]
4. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
[TBL] [Abstract][Full Text] [Related]
5. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
Tigges MA; Leng S; Johnson DC; Burke RL
J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
7. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes.
Posavad CM; Koelle DM; Corey L
J Virol; 1996 Nov; 70(11):8165-8. PubMed ID: 8892947
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.
Zhu J; Koelle DM; Cao J; Vazquez J; Huang ML; Hladik F; Wald A; Corey L
J Exp Med; 2007 Mar; 204(3):595-603. PubMed ID: 17325200
[TBL] [Abstract][Full Text] [Related]
10. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.
Koelle DM; Frank JM; Johnson ML; Kwok WW
J Virol; 1998 Sep; 72(9):7476-83. PubMed ID: 9696844
[TBL] [Abstract][Full Text] [Related]
11. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.
Koelle DM; Abbo H; Peck A; Ziegweid K; Corey L
J Infect Dis; 1994 May; 169(5):956-61. PubMed ID: 8169426
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and blood.
Barcy S; Huang ML; Corey L; Koelle DM
J Infect Dis; 2005 Jun; 191(12):2012-21. PubMed ID: 15897986
[TBL] [Abstract][Full Text] [Related]
13. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.
Dong L; Li P; Oenema T; McClurkan CL; Koelle DM
J Immunol; 2010 Mar; 184(6):3063-71. PubMed ID: 20139278
[TBL] [Abstract][Full Text] [Related]
14. Homing in on the cellular immune response to HSV-2 in humans.
Koelle DM; Gonzalez JC; Johnson AS
Am J Reprod Immunol; 2005 Apr; 53(4):172-81. PubMed ID: 15760378
[TBL] [Abstract][Full Text] [Related]
15. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells.
Wills MR; Carmichael AJ; Weekes MP; Mynard K; Okecha G; Hicks R; Sissons JG
J Immunol; 1999 Jun; 162(12):7080-7. PubMed ID: 10358151
[TBL] [Abstract][Full Text] [Related]
16. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.
Zhu J; Peng T; Johnston C; Phasouk K; Kask AS; Klock A; Jin L; Diem K; Koelle DM; Wald A; Robins H; Corey L
Nature; 2013 May; 497(7450):494-7. PubMed ID: 23657257
[TBL] [Abstract][Full Text] [Related]
17. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1988 May; 140(10):3419-25. PubMed ID: 2452188
[TBL] [Abstract][Full Text] [Related]
18. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
19. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
Yasukawa M; Zarling JM
J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
[TBL] [Abstract][Full Text] [Related]
20. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
Danke NA; Koelle DM; Kwok WW
Hum Immunol; 2005 Jul; 66(7):777-87. PubMed ID: 16112025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
